Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2007; 13(30): 4126-4130
Published online Aug 14, 2007. doi: 10.3748/wjg.v13.i30.4126
Published online Aug 14, 2007. doi: 10.3748/wjg.v13.i30.4126
G3BP | RhoC | ||||||
Variables | n | - | + | P | - | + | P |
Tumor size (cm) | 5.0 ± 2.1 | 5.7 ± 2.9 | 0.265 | 5.1 ± 2.0 | 5.7 ± 3.0 | 0.396 | |
Differentiation | |||||||
Well | 43 | 14 | 29 | 0.717 | 17 | 26 | 0.469 |
Mediate | 24 | 6 | 18 | 7 | 17 | ||
Low | 13 | 3 | 10 | 3 | 10 | ||
TNM stage | |||||||
Stage 1 | 2 | 2 | 0 | 0.083 | 2 | 0 | 0.182 |
Stage 2 | 47 | 15 | 32 | 17 | 30 | ||
Stage 3 | 23 | 5 | 18 | 6 | 17 | ||
Stage 4 | 8 | 1 | 7 | 2 | 6 | ||
Lymph node metastasis | |||||||
No | 43 | 17 | 26 | 0.022 | 19 | 24 | 0.034 |
Yes | 37 | 6 | 31 | 8 | 29 |
- Citation: Zhang HZ, Liu JG, Wei YP, Wu C, Cao YK, Wang M. Expression of G3BP and RhoC in esophageal squamous carcinoma and their effect on prognosis. World J Gastroenterol 2007; 13(30): 4126-4130
- URL: https://www.wjgnet.com/1007-9327/full/v13/i30/4126.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i30.4126